GWINNETT COUNTY, Ga. — Boehringer Ingelheim Animal Health USA Inc., a leading animal health company plans to build a new site in Gwinnett County.
The announcement was made today by Gov. Brian Kemp. The new site is said to create 225 jobs and more than $120 million in investments in Gwinnett, Clarke, and Hall counties.
The company has located its North American headquarters in Duluth, creating 75 new jobs; is adding more than 100 new jobs at its manufacturing and R&D facility in Athens; and more than 50 jobs at the company’s Gainesville manufacturing facility.
“We’re excited to welcome Boehringer Ingelheim Animal Health USA Inc. to the Peach State,” said Governor Kemp. “As a family-owned business, they will join a first-class corporate family here in Georgia. I look forward to working with them to strengthen our university system and existing industries in agribusiness, health technology, and science.”
Originally stationed in Ingelheim, Germany, Boehringer Ingelheim operates globally with 145 affiliates and around 47,500 employees. The focus of the company, is researching, developing, manufacturing, and marketing new medications of high therapeutic value for human and veterinary medicine.
“It’s a great day in Georgia when we can announce that a project will spur job creation in three counties,” said Georgia Department of Economic Development Commissioner Pat Wilson. “I would like to congratulate our partners in Athens-Clarke, Hall, and Gwinnett counties for their hard work and commitment to making Georgia a place where companies want to live, work, and play.”
“This announcement is yet another excellent example of how Gwinnett’s robust business climate and diverse community continue to draw companies to locate and expand here,” said Nick Masino, Chief Economic Development Officer at Partnership Gwinnett. “Industry giants, like Boehringer Ingelheim, recognize Gwinnett County as a prime location to better reach their target markets and grow their business.”
Want more Gwinnett news? Like us on Facebook.
